KAISA HEALTH (00876): The Chinese stock short name will be changed to "Qinghai Biopharmaceutical"

KAISA HEALTH (00876) announced that, following shareholder approval of the change of company name at the special general meeting, the name of the Company has been changed from "Kaisa Health Group Holdings Limited" to "Qinghai Biotech Pharmaceutical Group Limited", and "" has been adopted as the Company's secondary name in Chinese, in replacement of the former Chinese name "KAISA HEALTH", both with effect from September 3, 2026, pursuant to the certificate of change of name and the certificate of secondary name issued by the Registrar of Companies in Bermuda on September 3, 2026. The Registrar of Companies in Hong Kong issued a certificate of registration of change of name of a non-Hong Kong company on September 18, 2026, confirming that the Company's new English and Chinese names (the change of company name) are registered in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong). Following the change of company name, the English stock short name for trading of the shares on the Hong Kong Stock Exchange will be changed from "KAISA HEALTH" to "QH BIO PHARMA", and the Chinese stock short name will be changed from "KAISA HEALTH" to "", with effect from 9:00 a.m. on September 28, 2026. The Company's stock code on the Hong Kong Stock Exchange remains unchanged as "876".